P-62 IDO inhibits T-cell function through suppressing Vav1 expression and activation
Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, China
1Hematology and Oncology, Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Iran, 2Department of Biochemistry, Tabriz University of Medical Sciences
P-64 Determination of warfarin dose requirement in thrombotic and embolic disorders in Iran
1Hematology and Oncology, Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Iran, 2Department of Nehrology, Tabriz University of MedicalSciences, 3Department of Norology, Tabriz University of Medical Sciences, 4Medicine Faculty, Tabriz University, 5Department of Nehrology, Hamedan University of Medical Sciences, 6Labrotorist, Loghman Hospital, Tehran
P-65 HDAC inhibitor SAHA inhibits in vitro hypoxia-induced CXCR4 up-regulation in AML cells
1Division of Medical Oncology and Hematology and Infectious Disease, Department of Internal Medicine, Fukuoka University, Japan, 2Central Laboratory of Pathology and Morphology, Fukuoka University, Japan, 3Department of Pharmaceutics, Fukuoka University, Japan, 4Department of Medicine, Fukuoka University, Japan, 5Department of Medicine, Shimane University, Japan
P-66 ASHWAGANDHA LEAF EXTRACT AND ITS COMPONENTS INDUCE DIFFERENTIATION IN HUMAN GLIOBLASTOMAS
1Graduate School of Life and Environmental Sciences, Tsukuba University, Japan, 2Graduate School of Life & Environmental Sciences, University of Tsukuba, Japan, 3National Institute of Advanced Industrial Science & Technology (AIST), Central 4, Tsukuba, Japan
Food Toxicology Division, Indian Institute of Toxicology Research, India